In this video, James Cleary, MD, PhD, a medical oncologist at Dana-Farber Cancer Institute, discussed new developing treatment options for biliary tract cancer presented at the American Association for Cancer Research Annual Meeting.
Cleary highlighted results from a combination therapy of pembrolizumab and gemcitabine that provided new optimism that immunotherapy can prolong life among biliary tract cancer patients.
“The effect is modest, but it’s real,” Cleary said. “If I was a patient with biliary tract cancer this is a therapy I’d want.”